IFNG and hepatocellular carcinoma: These findings indicate that circulating NK cells lose their capacity to produce IFN-γ in advanced HCC, hindering anti-tumor immune response in patients with HCC, and these defects are aggravated with HCC progression regardless of the total NK cell number.